Stock Analysis

Taiwan Hon Chuan Enterprise Second Quarter 2024 Earnings: EPS Beats Expectations, Revenues Lag

TWSE:9939
Source: Shutterstock

Taiwan Hon Chuan Enterprise (TWSE:9939) Second Quarter 2024 Results

Key Financial Results

  • Revenue: NT$7.50b (up 3.8% from 2Q 2023).
  • Net income: NT$868.8m (up 12% from 2Q 2023).
  • Profit margin: 12% (in line with 2Q 2023).
  • EPS: NT$3.02 (up from NT$2.69 in 2Q 2023).
earnings-and-revenue-growth
TWSE:9939 Earnings and Revenue Growth August 18th 2024

All figures shown in the chart above are for the trailing 12 month (TTM) period

Taiwan Hon Chuan Enterprise EPS Beats Expectations, Revenues Fall Short

Revenue missed analyst estimates by 4.5%. Earnings per share (EPS) exceeded analyst estimates by 4.1%.

Looking ahead, revenue is forecast to grow 10% p.a. on average during the next 2 years, compared to a 14% growth forecast for the Packaging industry in Asia.

Performance of the market in Taiwan.

The company's shares are up 7.1% from a week ago.

Risk Analysis

You still need to take note of risks, for example - Taiwan Hon Chuan Enterprise has 3 warning signs we think you should be aware of.

Valuation is complex, but we're here to simplify it.

Discover if Taiwan Hon Chuan Enterprise might be undervalued or overvalued with our detailed analysis, featuring fair value estimates, potential risks, dividends, insider trades, and its financial condition.

Access Free Analysis

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.